Skip to main content
. Author manuscript; available in PMC: 2024 Aug 2.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2022 Oct 26;31(12):106845. doi: 10.1016/j.jstrokecerebrovasdis.2022.106845

Table 5.

The directly acquired mRS and converted GOS for the two arms of the INTERACT2 study including the proportion of individuals with poor outcome (the primary INTERACT2 study outcome). The scores were converted using the conversion tables in Table 3.

Intensive blood-pressure lowering (n=1382) Guideline-recommended blood pressure lowering (n=1412)

Directly acquired mRS
0 112 (8.1%) 107 (7.6%)
1 292 (21.1%) 254 (18.0%)
2 259 (18.7%) 266 (18.8%)
3 220 (15.9%) 234 (16.6%)
4 250 (18.1%) 268 (19.0%)
5 83 (6.0%) 113 (8.0%)
6 166 (12.0%) 170 (12.0%)
Primary outcome: mRS=3–6 719 (52.0%) 785 (55.6%)
Converted GOS
1 166 (12.0%) 170 (12.0%)
2 - -
3 553 (40.0%) 615 (43.6%)
4 259 (18.7%) 266 (18.8%)
5 404 (29.2%) 361 (25.6%)
Converted primary outcome: GOS=1–3 719 (52.0%) 785 (55.6%)